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Abstract: We demonstrate the application of fluorescence lifetime optical 
projection tomography (FLIM-OPT) to in vivo imaging of lysC:GFP 
transgenic zebrafish embryos (Danio rerio). This method has been applied 
to unambiguously distinguish between the fluorescent protein (GFP) signal 
in myeloid cells from background autofluorescence based on the 
fluorescence lifetime. The combination of FLIM, an inherently ratiometric 
method, in conjunction with OPT results in a quantitative 3-D tomographic 
technique that could be used as a robust method for in vivo biological and 
pharmaceutical research, for example as a readout of Förster resonance 
energy transfer based interactions. 
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1. Introduction 
Research into biomolecular signaling and disease mechanisms has progressed from average 
measurements on cell populations and extracts to “high content” imaging of single cells, both 
fixed and viable. This provides morphological information that can be related to physiology 
and phenotype and allows spatial and/or temporal analysis of variations in the intracellular 
distribution of molecules and their interactions. Increasingly, such high content analysis 
(HCA) is being implemented in automated imaging systems capable of assaying sample 
arrays at sufficient rates to screen against gene libraries. In conjunction with advances in 
labeling technology, particularly genetically expressed fluorescent proteins [1], this 
progression to HCA has driven the development of quantitative fluorescence microscopy 
techniques. Of particular interest is Förster resonance energy transfer (FRET) [2,3], which can 
be used to detect and monitor interactions between proteins labeled with appropriate (donor 
and acceptor) fluorophores. FRET can also be used to measure conformational changes of 
large molecules and is increasingly used to read out genetically expressed biosensors for 
signaling molecules such as calcium [4], potassium [5], chloride [6], GTP [7], IP3 [8], PIP2 
[9] and others [10]. FRET is an example of fluorescence emission reporting variations in the 
local fluorophore environment (specifically the proximity of another fluorophore) and there 
are many other applications where such functional information can be obtained by exploiting 
fluorophores as sensors. In principle the fluorophore environment can be assayed by 
measurements of intensity through its dependence on quantum efficiency, but such 
measurements require knowledge of the probe concentration and the excitation and detection 
efficiencies, which is often not available in biological experiments and can be compromised 
by sample attenuation and scattering. This issue may be addressed by ratiometric imaging 
techniques, of which fluorescence lifetime imaging (FLIM) [11–13], measuring the average 
relaxation time of excited fluorescent molecules, is one of the most robust. 
While FRET microscopy is in widespread academic use, it has yet to see significant 
uptake for drug discovery owing to the difficulties associated with acquiring sufficiently 
robust quantitative data. This might be mitigated using FLIM, but while there are now several 
commercially available FLIM microscope systems there are few reports of FLIM 
implemented for HCA in multiwell plate readers. This is partly due to the relatively low 
imaging speeds of the most common implementations of FLIM that are realized in laser 
scanning microscopes. We have recently reported a high-speed optically sectioning FLIM 
multiwell plate reader [14] able to acquire images in less than a second and believe that this 
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cell signaling networks. Unfortunately, however, the results of multiwell plate assays do not 
always translate along the drug discovery pipeline to clinical efficacy and there is a growing 
appreciation that in vitro cell mono-layers may exhibit non-physiological behavior due to their 
highly-artificial environment. This has led to increasing interest in assays implemented in 
three-dimensional (3-D) cell cultures [15] and in more physiologically realistic engineered or 
in vivo environments [16,17]. For drug discovery and many biological studies, there is 
increasing interest in live disease models that can be developed in organisms such as 
Drosophila, Caenorhabditis elegans and zebrafish embryos, which are optically accessible 
and can be genetically manipulated. Our vision is to develop high content assays of 
biomolecular interactions that can be translated from in vitro microscopy and analysis of 
cultured cells to 3-D analysis of disease models and in live organisms from embryonic to adult 
stages. Accordingly we are working to extend FLIM from microscopes and plate readers to in 
vivo imaging of model organisms and small animals. For larger animals this can be realized 
through intravital microscopy, which has been applied to in vivo FRET [18] and FLIM [19]. 
The limited depth penetration of microscopy, however, restricts this approach to image 
superficial tissues or implementation in conjunction with highly invasive surgical procedures. 
For larger animals, internal tissues could be accessed using FLIM endoscopy. While this has 
not yet been demonstrated, we have reported the first confocal FLIM microendoscope [20], 
which has recently been shown to be able to read out FRET in live cells in less than 2 seconds 
[21]. 
While optically sectioned imaging of relatively thin samples (<1 mm) is readily achievable 
with confocal/multiphoton microscopy, particularly for transparent samples, full 3-D imaging 
can be very time consuming and may not be possible for larger samples. To address this 
challenge for samples in the 1-10 mm range, often referred to as the “mesoscopic” regime, 
various tomographic techniques have been developed such as selective plane illumination 
microscopy (SPIM) [22], ultramicroscopy [23] and optical projection tomography (OPT) [24]. 
The first two of these techniques use orthogonal illumination and imaging axes, with the 
sample being illuminated by a “sheet” of light, defining the sectioning strength, and imaged 
using a standard wide-field system, defining the lateral resolution. This orthogonal geometry 
can provide significantly reduced photobleaching and improved axial resolution compared to 
confocal microscopy. SPIM and ultramicroscopy are limited to fluorescence imaging and 
typically require a different optical configuration to a standard microscope, although some 
implementations can be retrofitted to conventional inverted microscopes [25]. In contrast 
OPT, which is the optical equivalent of X-ray computed tomography, can be applied to 
reconstruct the absorption and/or fluorescence distributions in optically transparent samples 
and can be applied over sub-mm to ~cm scales. For small samples, OPT can be implemented 
on a standard wide-field microscope with only minor modifications. 
The requirement of optical transparency for mesoscopic imaging techniques is, however, a 
major limitation. For less transparent and larger organisms chemical clearing techniques are 
required, which not only precludes the possibility of in vivo imaging, but can also have an 
adverse effect on the fluorescence properties of genetically expressed fluorescent proteins 
[26,27]. Some small organisms are sufficiently transparent to be imaged in vivo such as D. 
melanogaster [22] and Danio rerio [28] imaged using SPIM, and D. melanogaster [29] and C. 
elegans [30] imaged using OPT. We demonstrate here that it is possible to apply OPT to live 
zebrafish embryos labeled with genetically expressed fluorescent proteins up to at least ~3 
days post-fertilization. We believe that this presents a significant advance since zebrafish are 
an attractive vertebrate animal model for biological and pharmacological research [31] due to 
their relatively easy maintenance and housing, short reproductive cycle, extensively 
sequenced genome, the potential for manipulation using well established genetic and 
molecular approaches and easy drug administration. Zebrafish have successfully applied in 
toxicology bioassays for on and off target effects [32–34], organ function assays [35] and to 
model diseases [36]. 
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imaging methods implemented in microscopy, but have largely been limited to mapping 
intensity. This can provide 3-D reconstructions of fluorescent label distribution (e.g. probe 
localization and sample structure) and time-lapse (motion) data when applied to live 
specimens [22,37]. Extracting quantitative information beyond localization, however, is 
difficult due to the spatial variation in excitation and collection efficiency of fluorescence 
light, the variation in staining efficiency of chemical labels or expression levels of genetic 
fluorophores and variations in sample attenuation (“inner filter” effect). FLIM can provide a 
robust approach to quantitative readouts and we previously demonstrated the extension of 
OPT to FLIM-OPT of fixed and optically cleared samples [38], showing how the ratiometric 
nature of FLIM makes it insensitive to intensity variations. In that experiment, FLIM was able 
to distinguish between Alexa-488-labeled neurofilament and the autofluorescence from the 
heart and dorsal aorta of a fixed and cleared mouse embryo. 
(a) (b)
 
Fig. 1. Single frames from videos showing (a) a live zebrafish embryo (Media 1) mounted in 
the OPT system and (b) an intensity-based in vivo OPT acquisition (Media 2) of a lysC:GFP 
zebrafish embryo. Scale bar 500 μm. 
In this paper we report the first application of OPT to live transgenic zebrafish embryos 
and the first full body 3-D fluorescence lifetime imaging of a live animal model for biological 
research and drug discovery, which we believe can be applied in primary screening before the 
expensive mammal testing phase, providing functional readouts at higher resolution than is 
possible in mammals. 
2. Materials and methods 
2.1. Sample preparation and mounting 
A transgenic zebrafish line (lysC:GFP, lysC-GFP were produced by Philip S. Crosier, 
University of Auckland 1142, NZ [39,40]) which express GFP in myeloid cells, was used as 
an exemplar model for in vivo imaging. Embryos were raised in embryo medium 
(dechlorinated system water containing 0.0003% (v/v) methylene blue and 30µg/ml N-
phenylthiourea (Sigma) to prevent melanization). Embryos at 3 days post-fertilization were 
immobilized in 1% low melt point agarose (Flowgen, Lichfield, UK), made from embryo 
media, containing 0.3 mM MS-222 (Sigma) as anesthetic. They were then drawn into short 
lengths of translucent FEP tubing (06406-60, Cole-Palmer) with inner and outer diameters of 
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can be used in an index matched chamber for imaging applications [41]. Agarose was added 
to increase the viscosity of the water and prevent movement of the anaesthetized zebrafish 
under the action of gravity. Figure 1(a) shows a live zebrafish embryo (demonstrated by 
beating heart) imaged at 20 frames per second mounted in the FEP tubing. 
2.2. Experimental set-up and reconstruction 
A custom-built chamber was fabricated to hold the tube-mounted zebrafish embryos in a 
refractive index-matched environment and to allow stable sample rotation without lateral 
movement, as is required for OPT (see Figs. 1(b) and 2). The samples were imaged on a 
standard inverted wide-field microscope (IX-71, Olympus UK Ltd), utilizing both 
epifluorescence and transmitted light imaging with a 4x objective (UPLFLN4X, Olympus UK 
Ltd) and a filter cube for GFP (GFP-3035B-OMF, Laser 2000 Ltd). An aperture positioned 
directly behind the objective limited its numerical aperture to 0.07. During a standard OPT 
acquisition, fluorescence and/or transmitted light images are acquired at equal angular 
intervals as the sample rotated (e.g. acquiring images every 1° over a full rotation). The 
transmitted light images were acquired using the incandescent lamp and images were acquired 
through the GFP filter that has a spectral pass band of 525 ± 25 nm. 
(a) (b)
 
Fig. 2. (a) Schematic of OPT system. O – objective, AP – aperture, L1 – condenser lens, F1 – 
excitation filter, DM – dichroic mirror, L2 – tube lens, F2 – emission filter, M – mirror. (b) 
Photograph of custom built chamber. 
To implement FLIM we employed wide-field time-gated imaging using a gated optical 
intensifier (GOI). Wide-field excitation was provided by a spectrally-filtered (472 ± 15 nm) 
ultrafast fiber-laser-pumped super-continuum source (SC-400-2, Fianium Ltd) [42]. The 
emitted fluorescence was imaged onto the photocathode of the GOI (HRI, Kentech 
Instruments Ltd), which could be gated with an adjustable delay relative to the excitation 
pulses, for which the gate-width was set to 1 ns. The GOI phosphor was imaged onto a CCD 
camera (Clara, Andor Technology plc). Intensifier gate delays were adjusted using a 
computer-controlled electronic delay line (HDG, Kentech Instruments Ltd) that was 
synchronized to the excitation laser. During a typical acquisition, 5 time-gated images were 
recorded at 1 ns relative delay positions every 4° (i.e. a total of 450 images were recorded). In 
addition to the time-gated fluorescence images, a single transmitted light image was acquired 
every 1° through the same filter. The total acquisition time for the data set was ~20 minutes. 
Each frame had an integration time of 1 s and 0.5 s for the time-gated and transmitted light 
acquisitions respectively, leading to a total camera integration time of 630 s. The remaining 
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switching between fluorescence and transmission modes and can be significantly reduced. 
The GOI has an effective pixel size of ~26 μm and used in this optical configuration results in 
an in-focus lateral spatial resolution of ~13 μm. 
(a) (b)
 
Fig. 3. (a) An OPT raw data set comprises a set of wide-field images as a function of rotation. 
Reconstruction is performed using the sinograms (r-θ planes) for each row of pixels. (b) Single 
frame showing the reconstruction of a single slice from 90 fluorescence projections (Media 3). 
Scale bar 500 μm. 
3-D image reconstruction was realized using a back-projection algorithm. Assuming a 
parallel projection regime, each row of pixels in an acquired image can be considered a 1-D 
projection, i.e. a sum along the direction of the optical axis, of a 2-D slice through the sample. 
As the sample rotates, these individual 1-D projections, Pθ(r), make up the sinogram (see Fig. 
3(a)). From the sinogram the signal (e.g. the fluorescence intensity) at each point in a 2-D 
slice through the sample can be reconstructed using an inverse Radon transform, as described 
by Eq. (1), where Sθ(w) is the Fourier transform of Pθ(r), w is the spatial frequency and θ is 
the angle at which the projection was acquired. During this “filtered back-projection” 
reconstruction process, the measured projection is Fourier transformed, filtered by |w| to 
account for the spatial frequency sampling as the object rotates, inverse Fourier transformed 
and back-projected or smeared across a 2-D plane at the corresponding acquisition angle, then 
repeated for every projection [24,43] (see Fig. 3(b)). 
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This reconstruction approach is repeated for each set of time-gated measurements 
corresponding to each time delay. In this case, five time-gated 3-D intensity reconstructions of 
the fluorescence signal were obtained. The intensity decay in corresponding voxels of the 
time-gated reconstructions was then determined, assuming a single exponential fluorescence 
decay model, using an in-house fitting algorithm based on non-linear least squares 
optimization. This produced 3-D reconstructions of both the integrated fluorescence intensity 
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merged with the integrated intensity to suppress noise in regions with little or no signal. 
3. Results 
Figures 4(a) and (b) show a 3-D fluorescent intensity reconstruction and an animation of the 
combined absorption (grayscale) and fluorescence (red) reconstruction respectively of a 
transgenic zebrafish (lysC:GFP), for which the expression of GFP is limited to myeloid cells 
(e.g. neutrophils and macrophages). We would therefore expect the fluorescence 
reconstruction to show a distribution of these cells throughout the embryo. In the raw data and 
reconstruction, however, a significant autofluorescence signal can also be observed, 
particularly in the region of the remaining yolk-sac. Without a priori knowledge of the 
expected fluorescent protein distribution, it is difficult to distinguish this signal from induced 
background fluorescence, since both signals will vary spatially in intensity due to uneven 
expression level, illumination and collection efficiency and artifacts in the reconstruction 
process. The GFP signal can, however, be clearly distinguished from autofluorescence via the 
fluorescence lifetime. Figure 5(a) shows the corresponding fluorescence lifetime 
reconstruction, for which the fluorescence lifetime is encoded in the color scale. The 
separation of lifetimes is such that the reconstruction can be viewed on a discrete color scale 
(Fig. 5(b)), showing the GFP signal in green and autofluorescence in blue. This contrast is 
confirmed by the fluorescence lifetime histogram (Fig. 5(c)), which shows these two distinct 
lifetime populations and confirms that the correct lifetime of ~2.5ns has been determined for 
GFP. 
We note that the data sets presented here represent “single time-point” acquisitions and so 
the time-lapse resolution for this FLIM-OPT acquisition is therefore ~20 minutes, the total 
data acquisition time. As a result we would not accurately reconstruct the position and 
fluorescence lifetime of features that move a significant distance during this acquisition time. 
Furthermore, the acquisition was not synchronized with the heartbeat of the zebrafish and so 
the reconstructed image in close proximity to the heart will be compromised by the time-
averaged motion. The total FLIM-OPT acquisition time can be decreased by optimizing the 
excitation powers and labeling density, by sampling the fluorescence decays with fewer time  
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Fig. 4. (a) A 3-D fluorescence intensity reconstruction and (b) a single frame showing 
combined fluorescence (red) and transmitted light (grey) intensity reconstructions of a live 
lysC:GFP transgenic zebrafish embryo 3 days post-fertilization (Media 4). Scale bar 500 μm. 
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Fig. 5. Single frames showing  3-D fluorescence lifetime reconstructions on a (a) continuous 
(Media 5) and (b) discrete color scale (Media 6) of a live lysC:GFP transgenic zebrafish 
embryo 3 days post-fertilization. (c) A fluorescence lifetime histogram showing two clear 
populations corresponding to GFP and autofluorescence. Scale bar 500 μm. 
gates and by acquiring images at fewer angles of projection although this will, of course, 
compromise the achievable resolution and accuracy of the reconstructed images. We note, 
however, that (FLIM) OPT, can potentially provide information with much higher time-lapse 
resolution than the total data acquisition time by tracking the movement of sample features. 
For example, by acquiring sequential frames at 90° with respect to each other, it should be 
possible to track the movement of features such as myeloid cells with a time-lapse resolution 
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calculate the 3-D coordinates of the moving features. 
The tomographic image reconstruction approach used in this demonstration of in vivo 
FLIM-OPT was based on filtered back-projection, calculated using in-house software 
implemented in MatLab (Mathworks Inc). The FLIM reconstruction shown in Fig. 5 is 
comprised of a back-projection reconstruction corresponding to each of the 5 time-gates 
sampling the fluorescence decays, followed by iterative fitting to determine the fluorescence 
lifetime in every voxel. This post-processing took ~20 minutes running on a personal 
computer (2.66 GHz, 3.25 GB RAM). The required processing time could be significantly 
reduced by parallel processing on multicore computers [44] or by taking advantage of the 
speed of graphics processor units [45]. In addition, if the fluorescence lifetimes are known in 
advance, an optimized gating strategy can be used to minimize the required number of time-
gates (e.g. 2 gates for a single exponential [46,47]) and therefore reduce the number of 3-D 
reconstructions required. We note that, since we are imaging with ballistic light, the 
fluorescence lifetime resolution is determined by the wide-field FLIM system and should be 
similar to that obtainable in FLIM microscopy, being a function of the instrument response 
function and the signal to noise ratio. The performance of our time-gated FLIM system has 
previously been discussed in e.g [21,48]. 
With respect to sample viability, we note that the zebrafish embryos were alive (with 
beating heart) at the end of our experiments. While we have not yet been able to determine 
their long term viability, we have performed multiple fluorescence intensity OPT acquisitions 
of zebrafish (data not shown), including two single time-point acquisitions of the same 
zebrafish separated by 48 hours, during which time the zebrafish embryo appeared to develop 
normally, and a first time lapse study involving 20 intensity OPT acquisitions (each of ~20 s 
at 2 minute intervals. In both cases the fish were still alive at the end of the experiments. 
4. Conclusions 
Here we report in vivo OPT and FLIM-OPT of intact viable zebrafish embryos. In order to 
achieve this result, we have constructed a refractive index-matched chamber designed for in 
vivo wide-field imaging [41] with computer controlled stable rotation of the sample, as is 
required for OPT. This technique was implemented on a standard wide-field fluorescence 
microscope and, in general, OPT can be implemented in almost any wide-field imaging 
instrument, essentially only requiring the addition of a means to achieve the sample rotation. 
In principle, this can be extended to FLIM-OPT by incorporating any wide-field FLIM 
instrumentation. Here we have implemented time-gated imaging, utilizing a tunable 
supercontinuum excitation source to provide spectral versatility. We note, however, that 
FLIM could also be realized in the frequency domain using a sinusoidally modulated image 
intensifier. Looking forward, it may be possible to develop a lower cost implementation using, 
for example, a directly modulated CMOS camera for detection [49] and sinusoidally 
modulated LED sources for excitation [50]. The OPT reconstruction method used here was 
based on filtered back-projection, but it could be improved by using more sophisticated 
approaches that incorporate the characteristics of the imaging system as a function of defocus 
[51]. Further advances in the reconstruction process could incorporate optical properties of the 
specimen including light scattering properties for particular regions (e.g. yolk-sac, eyes) [52]. 
We have also shown the ability of FLIM to distinguish between an expressed fluorescent 
protein signal and background autofluorescence in 3-D reconstructions, noting that 
autofluorescence from the yolk-sac is a particular issue for zebrafish embryos. Thus this work 
demonstrates the feasibility of using fluorescence lifetime contrast with OPT to provide 
functional imaging for the investigation of 3-D biological processes in vivo. We believe that it 
may be feasible to adapt this approach to automated imaging to achieve a higher throughput, 
e.g. following [53]. It may also be possible to devise a scheme to image multiple zebrafish in 
a single acquisition to increase imaging throughput, although this would compromise the 
achievable resolution. 
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labels with similar spectral properties but different lifetime values and to map 3-D variations 
in local fluorophore environment, such as membrane lipid order [54], analyte concentration 
(e.g. calcium [21]) and FRET. By utilizing specific FRET sensors for probing particular 
interactions in a signaling pathway or indicating the concentration of specific molecules, 
FLIM-OPT can provide both 3-D spatial localization and molecular information in 
transfected/transgenic zebrafish. Combining this with time-lapse acquisition in live samples 
will allow investigators to correlate 3-D motion with molecular signaling events, for example 
in elucidating the control and signaling mechanisms behind cell migration during the innate 
immune response. 
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